By MARY GARY KELLY, Associated PressThe U.S. Food and Drug Administration on Tuesday approved the use of cannabidiol (CBD) oil for treating a number of conditions, including seizures and multiple sclerosis, and is the latest step in the movement to legalize marijuana for medical use.CBD oil is a natural compound derived from cannabis, which is derived from the seeds of the cannabis plant.
It’s been used for decades as a natural alternative to opioids, such as morphine, which has been used to treat chronic pain and cancer.
The FDA approved the oil in February.
The drug will be licensed to patients who have at least a 90-day supply of CBD and must have at-home testing.
“We are excited about the potential of cannabiloids to improve patient outcomes,” said the agency’s assistant commissioner of health, Dr. Jonathan Stowe.
The agency also approved a form of CBD oil called cannabiglyphs that are used to deliver THC, the psychoactive ingredient in marijuana, into the brain and spinal cord.
CBD is believed to be the primary component in cannabis, and the FDA said it is safe and effective for treating conditions such as nausea and anxiety.
The DEA said CBD oil should not be used as a first-line treatment for seizures.
The agency said it expects to continue to study CBD’s use in a variety of conditions.
The move comes as the Obama administration has begun moving toward a policy of allowing medical marijuana.
The White House said Monday that it has authorized the DEA to allow some use of marijuana for certain conditions.
“As the president has made clear, the U.N. treaties and conventions and the Controlled Substances Act are the law of the land and all Americans have the right to use cannabis as they see fit,” White House press secretary Josh Earnest said in a statement.
“That’s why we’ve made it a priority to review the regulations governing the production, distribution, and use of cannabis in the U,S.
and around the world, and will continue to work to ensure that marijuana is available for all Americans to use and grow.”CBD is one of a number medical products that are poised to become legal in the coming months.
The Drug Enforcement Administration on Monday approved the sale of a CBD-based drug, THCV, for treating epilepsy and other conditions.
Marijuana is already legal in 21 states and Washington, D.C.
The Drug Enforcement Agency said in April that it was considering allowing the use marijuana for treatment of certain neurological conditions, such to seizures, Parkinson’s disease and Huntington’s disease.